8 hrs ago | Circulation
Hypertension in Aortic Stenosis: Implications for Left Ventricular...
From the Institute of Medicine , University of Bergen, Bergen, Norway; Department of Heart Disease , Haukeland University Hospital, Bergen, Norway; Department of Medicine , Skellefteaa Hospital and Umeaa University, Skellefteaa, Sweden; Herz-Zentrum Bad Krozingen , Bad Krozingen, Germany; Department of Cardiology , Stavanger University Hospital, ... (more)
High Hopes for Sanofi (France)/Regeneron Pharmaceuticals, Inc. Cholesterol Drug
Sanofi and Regeneron Pharmaceuticals, Inc. today announced additional positive results from a Phase 2 trial of /REGN727 is a subcutaneously administered, fully-human antibody targeting PCSK9 in clinical development.
"Smruthi Organics Limited (590046) - Financial and Strategic SWOT Analysis Review" Published
It offers contract research, manufacturing and custom synthesis services to European, American and Japanese customers.
U.S. District Court rules in favor of Merck over ZETIA and VYTORIN patent litigation
Merck , known as MSD outside the United States and Canada, announced today that the U.S. District Court for the District of New Jersey has ruled in Merck's favor in two jointly related patent infringement suits against Mylan Pharmaceuticals Inc.
Also on Topix